Skip to main content
Molecular & Cellular Proteomics : MCP logoLink to Molecular & Cellular Proteomics : MCP
. 2014 Dec 2;14(2):289–302. doi: 10.1074/mcp.M114.043851

Dosage and Temporal Thresholds in microRNA Proteomics*

Thomas Lee ‡,§, Nan Wang ‡,§, Stephane Houel ‡,§,, Kasey Couts ‡,§,, William Old , Natalie Ahn ‡,§,**
PMCID: PMC4350026  PMID: 25467838

Abstract

MicroRNAs (miRNAs) modulate protein and mRNA expression through translational repression and/or mRNA decay. In this study, we combined SILAC-based proteomics and RNAseq to identify primary targets based on measurements of protein and mRNA repression and analysis of transcript 3′UTR sequences. The primary target set was used to compare different prediction algorithms, revealing higher stringency of selection by Targetscan and PITA compared with miRanda, at the expense of higher false negatives. A key finding was that significant and unexpected variations occurred in the kinetics of repression as well as the sensitivity to exogeneous miRNA concentration. Bimodal thresholds were observed, which distinguished responses to low (10 nm) versus high (50–100 nm) miRNA, as well as the onset of repression at early (12–18 h) versus late (36–48 h) times. Similar behavior was seen at the transcript level with respect to kinetics of repression. The differential thresholds were most strongly correlated with ΔΔG, the net free energy of miRNA-target interactions, which mainly reflected inverse correlations with ΔGopen, the free energy of forming 3′UTR secondary structures, at or nearby the miRNA seed matching sites. Thus, our working model is that protein binding or other competitive mechanisms variably interfere with the accessibility of miRISC to the transcript binding site. In addition, biphasic responses were observed in a subset of proteins that were partially down-regulated at early times, and further down-regulated at later times. Taken together, our findings provide evidence for varying modes of miRNA target repression, which lead to different thresholds of target responses with respect to kinetics and concentration, and predict that certain transcripts will show graded responses in sensitivity and fold-change under cellular conditions that lead to varying steady state miRNA levels.


microRNAs (miRNAs)1 are small noncoding RNAs that modulate cellular protein levels, impacting a wide range of processes ranging from cellular development and differentiation to cancer, metabolic disorder, and other human diseases (15). Mature miRNAs interact with Argonaute (AGO) family proteins to form miRNA-induced silencing complexes (miRISCs) (6, 7), which in turn attenuate protein expression through translational repression and/or mRNA decay mechanisms. In animal cells, miRISC interacts with mRNA-bound poly(A) binding protein C (PABPC) through a complex between AGO and the GW182 trinucleotide-repeat-containing protein. This interaction recruits deadenylation, 5′-decapping, and mRNA degrading enzymes, and also blocks eukaryotic translation initiation factor G (eIFG) binding to confer translational repression (811). Although the degree of protein or mRNA repression by miRNAs is often moderate (1.5- to 4-fold), fine-tuning at this level can be enough to shift cell and organismal phenotypes, or to set thresholds for gene and protein expression changes which control the robustness of cellular states (1215).

The specificity by which proteins are targeted by miRISC is determined by base-pairing between a “seed-sequence” at the 5′end of a miRNA and a “seed-matching sequence” in a targeted mRNA, typically located at the 3′UTR. Seed sequences are only 6–8 nt, therefore, a single miRNA can potentially target hundreds of different mRNAs. But many gene products containing seed-matching sequences are not true targets, leading to ambiguities in distinguishing primary targets from off-target (false positive) responses. Several algorithms have been developed to improve the accuracy of identifying miRNA primary targets (1621). These quantify scores based on additional features beyond seed sequence complementarity, determined from and validated by microarray evidence for mRNA repression. Such features include: 1) thermodynamic stability of miRNA–mRNA base pairing, 2) position and accessibility of seed matching sequences within the 3′UTR (21), 3) miRNA–mRNA base pairing in regions flanking the seed sequence (19), and 4) evolutionary conservation of seed-matching sequences, the latter is predictive for miRNAs that are conserved across mammalian and non-mammalian species (17, 18, 20). Although several studies have used SILAC-based LC-MS/MS methods to examine miRNA responses, it is not known how different prediction algorithms compare when evaluated by large-scale proteomics.

Data sets used to train and validate scores used by prediction algorithms prioritize responses measured within 24 h after transfection (19). A few studies have examined mRNA responses with respect to time and miRNA concentration. For example, responses to let-7 miRNA showed repression of cell cycle genes within 16–24 h, and postulated that early responding genes favor functional targets, whereas later responses are more likely to be indirect (22). In addition, mRNA repression was maximal at 20 nm siRNA added exogenously to HeLa cells (23, 24), suggesting that repression of primary targets saturates at low miRNA concentrations. However, in these studies, only one or a few target proteins were typically analyzed, and on a global scale, miRNA responses might in fact vary widely with respect to time and concentration. This has been rarely addressed at the mRNA level and has been unexplored at the protein level.

Here, we present a systematic, proteome-wide analysis of the kinetics and dose responses of protein changes in response to a single miRNA. Our findings show unanticipated variations among primary miRNA targets with respect to their sensitivity to exogenous miRNA concentration and the time at which they reach the threshold for significant change. Targets respond to miRNA concentration in a bimodal manner, where the more sensitive targets show higher free energies of miRNA–mRNA hybridization and reduced 3′UTR structural stability. Likewise, targets can be grouped into early versus late responding groups, which are also correlated with 3′UTR stability. Similar behavior is seen with mRNA transcripts, where mRNA destabilization and decay appears mostly concomitant with protein repression. The results show that among primary targets, wide variations in kinetics and dose response occur that reflect differences between transcripts with respect to miRNA–mRNA and 3′UTR stability. This expands the understanding of how the regulation of primary miRNA targets may vary under different cellular states.

EXPERIMENTAL PROCEDURES

Reagents

Heavy isotopically labeled Arg (13C615N4-Arg) and Lys (13C615N2-Lys) and medium-labeled Arg (13C6-Arg) were from Cambridge Isotope Laboratory (Andover, MA). Medium-labeled Lys (2H4-Lys) and light-labeled Arg and Lys (12C614N4) were from Sigma-Aldrich (St. Louis, MO). SILAC RPMI 1640 medium lacking Arg and Lys was from Pierce (Rockford, IL). Dialyzed fetal bovine serum (FBS) was from Invitrogen (Grand Island, NY). miRIDIAN miRNA double stranded oligonucleotides (“mimics”), miRIDIAN microRNA Mimic Negative Control #1 and #2 (“NT”), and Dharmafect 1 transfection reagent were from Dharmacon (Lafayette, CO). The Microplate BCA Protein Assay Kit (Reducing Agent Compatible) was from Thermofisher Scientific (Rockford, IL), and Vivacon 500 (30k MWCO) spin filters were from Sartorius Stedim (Bohemia, NY). Modified trypsin was from Promega (Madison, WI), and the RNeasy® Mini kit was from Eppendorf (Germantown, MD).

Cell Culture

WM239A metastatic melanoma cells were cultured in RPMI supplemented with dialyzed 10% FBS. Static SILAC experiments were carried out as described (25, 26), by growing cells in RPMI/FBS containing heavy- or light-labeled Arg+Lys for at least five passages, before transfection with miRNA mimics or NTs. Pulsed SILAC (pSILAC) experiments were carried out as described (27), by maintaining cells in RPMI/FBS containing light Arg+Lys, which upon transfection was changed to either RPMI/FBS containing heavy or medium Arg+Lys.

Cell Transfection

miRNA mimics or nontargeting controls were mixed with Dharmafect 1 in serum-free RPMI and incubated at room temperature for 30 min. The miRNA-lipid mixture was added to 1 × 106 cells on a 6 cm plate in RPMI/FBS. In static SILAC experiments, the RPMI/FBS was changed 24 h after transfection and cells were harvested 24 h later. In pSILAC experiments, RPMI/FBS was not changed during time courses to avoid inconsistent media exposure. Cells transfected with nontargeting miRNAs had growth rates and adherence comparable to untransfected cells, thus showing no evidence for cytotoxicity.

Cells were harvested by adding lysis buffer (0.15 ml) containing 4% SDS, 20 mm DTT, and 0.1 m Tris, pH 8.6, to each plate. Lysates were incubated at 95 °C for 5 min, sonicated, and then clarified by centrifugation (14,000 × g, 15 min). Proteins were quantified using the microplate BCA protein assay, and 125 μg each of miRNA-treated cell lysates and NT-treated cell lysates were mixed and processed using the filter-aided sample preparation (FASP) protocol (28). Briefly, cell lysates were loaded onto Vivacon 500 spin columns and washed with 8 m urea, 0.1 m Tris, pH 8.6, (0.2 ml). Proteins were alkylated with iodoacetamide (50 mm), washed with urea/tris solution, and equilibrated with 0.1 m ammonium bicarbonate (0.2 ml) followed by overnight proteolysis with 1% (w/w) trypsin at 37 °C. Tryptic peptides were recovered through the filter by centrifugation, dried by speed-vac centrifugation, and stored at −80 °C. Peptides were dissolved in 36 μL 0.1% (v/v) formic acid and 10 μL (28%) was analyzed by 2D-LC-MS/MS.

2D-UPLC-ESI MS/MS

Samples were separated by online 2D RP–RP UPLC using a Waters nanoACQUITY system. The first dimension separation was performed on a XBridge C18 NanoEase column (3 μm, 300 μm x 50 mm) equilibrated in 20 mm ammonium formate, pH 10, (A) and eluted in acetonitrile (B). The second dimension separation was performed on a Symmetry C18 trap column (5 μm, 180 μm x 20 mm) and a BEH130 C18 analytical column (1.7 μL, 75 μm x 250 mm), equilibrated in 0.1% formic acid in water (A) and eluted with 0.1% formic acid and 80% acetonitrile (B). Peptide (34 μL, 10 μg) were separated in the first dimension by an 180step gradient (2 μL/min) (4% B in Step 1, with 1% B added with each step for Step 2–17; 65% B for Step 18). Each eluate was diluted by 1:9 with 0.1% (v/v) formic acid in water (20 μL/min) before loading onto the second dimension trap/analytical columns, followed by elution with 0–8% B between 0–2 min and 8–40% B between 2–123 min (0.3 μL/min). MS/MS was performed using an LTQ Orbitrap Velos, scanning MS between 475–1600 m/z (1 × 106 ions, 60,000 resolution), and selecting the 20 most intense MH22+ and MH33+ ions for MS/MS with 180 s dynamic exclusion, 10 ppm exclusion width, repeat count = 1. Maximal injection time was 500 ms for Orbitrap precursor scans with one microscan, and 250 ms for LTQ MS/MS with one microscan and AGC 1 × 104. The normalized collision energy was 35%, with activation Q = 0.25 for 10 ms.

Data Analysis

Raw data were processed using MaxQuant (version 1.0.13.13) (29) and Mascot (version 2.2.0, Matrix Science) used to search the peak list against IPI human database version 3.52 (73,928 entries) (30) with 262 common contaminant entries (31). The search allowed trypsin specificity with two missed cleavages, and included Cys carbamidomethylation as fixed and Met oxidation as variable modifications. MaxQuant used 7 ppm maximum initial mass deviation for the precursor ion, and 0.5 Da MS/MS tolerance, searching six top MS/MS peaks per 100 Da. False discovery rates were 0.01 for both peptide and protein identifications, with 0.5 maximum posterior envelope probability (PEP) for peptides, six amino acid minimum peptide length, and two minimum total peptides, of which at least one peptide must be unique (i.e. non-razor) for each protein identification. Protein quantifications used both razor and unique peptides, allowed unmodified peptides and peptides with oxidized Met, and required at least two ratio measurements with ratio variability < 75% for each protein. Protein ratios were reanalyzed and accepted when more than two-thirds of peptide ratios were within 0.15 from the median peptide ratio. The representative ID, which was supported by the greatest number of peptides in a protein group was used for further analysis. Protein abundance ratios between experimental and control conditions were accepted only when ratios of at least two different peptides per protein were measured. Normalized protein ratios were used in all experiments, except for experiments that measured protein half-life. The identified proteins and protein ratios from each analysis are summarized in supplemental Table S1.

Protein Half-life Measurements

Protein half-lives were estimated as described (32), plating unlabeled cells (5 × 105) on 6 cm dishes overnight, and initiating with 3 ml RPMI/FBS containing heavy-labeled Arg+Lys (t = 0 h). At t = 24 h, cells were harvested and analyzed by 2D-LC-MS/MS in triplicate experiments, from which Heavy/Light protein ratios were estimated, calculating the decay constant (k) for each protein from N(t) = N0ekt, where N(t) = 1/(1+Heavy/Light), N0 = 1, and t = 24, and t1/2 = ln2/k. Errors in t1/2 averaged from two or three measurements were less than 20% (supplemental Table S2).

3′UTR Sequence, Predicted Target List

Reference 3′UTR sequences of human mRNAs were downloaded from the UCSC genome browser (http://genome.ucsc.edu) (33), and a gene annotation file from NCBI (ftp.ncbi.nlm.nih.gov/genomes/H_sapiens/GFF/) was used to match protein against mRNA RefSeq IDs. Seed-matches within 3′UTR sequences were identified using an in-house Python script (supplemental Information). In Fig. 2, miR-22 targets were predicted using Targetscan with default settings (http://www.targetscan.org), and miRanda with miSVR score <0.1 (34), conserved miRNA settings (Aug. 2010 release), downloaded from microRNA.org (http://www.microrna.org/microrna/getDownloads.do). PITA scores (ΔΔG, ΔGopen, ΔGduplex) were downloaded without modification from the Segal lab webpage (http://genie.weizmann.ac.il/pubs/mir07/mir07_data.html).

Fig. 2.

Fig. 2.

Primary miRNA targets and performance of prediction algorithms. A, Venn diagram showing overlap between proteins corresponding to mRNAs containing at least one 3′UTR 7mer or 8mer (“seed-matches”) and proteins down-regulated in response to miR-22 measured by proteomics (“down-regulated”). B, Cumulative distribution of log2 (protein ratio) for proteins with 7mer/8mer (red) or no site (black) in their corresponding transcript 3′UTRs. In this and all subsequent figures, “ratio” refers to miR-22/NT. C, Overlap between miRanda-predicted targets, 7mer/8mer seed-matches, and down-regulated proteins measured by proteomics. D, Cumulative distribution of log2 (protein ratio) for miRanda-predicted targets containing 7mer/8mer seed matches (red), miRanda-predicted targets without 3′UTR seed-matches (green), all miRanda-predicted targets (orange), all 7mer/8mer seed-matching sequences (blue), or no site (black). E, Overlap between Targetscan-predicted targets, 7mer/8mer seed-matches, and down-regulated proteins. F, Cumulative distribution of log2 (protein ratio) for proteins with Targetscan-predicted targets (red), 7mer/8mer seed-matching sequences (blue), or no site (black). G, Overlap between PITA-predicted targets, 7mer/8mer seed-matches, and down-regulated proteins. H, Cumulative distribution of log2 (protein ratio) for proteins with PITA-predicted targets (red), 7mer/8mer seed-matching sequences (blue), or no site (black). I, Average log2 (protein ratio) for 375 seed-matches showing correlations with Targetscan PCT (r = −0.32, p < 10−6) and context score (r = 0.34, p < 10−6). Red lines show the best fits from linear regression analysis, with Pearson's correlation coefficients (R) and p values calculated using the full data set. J, Average log2 (protein ratio) for 330 seed-matches showing correlations with PITA-calculated ΔΔG (r = 0.11, p < 0.05), ΔGduplex (r = −0.01, p < 0.90), and ΔGopen (r = −0.13, p < 0.03). In panels I, and J, the seed matches were split into 10 equally spaced bins (x axis), where each measurement (y axis) represents the log2 (protein ratio) averaged over the seed matches in each bin (as in ref 19).

RNASeq Experiments

WM239A cells were transfected with 50 nm miR-22 or NT, and cells were harvested at 12, 18, 24, 36, and 48 h post-transfection. Total RNA was purified using RNAeasy Mini kit (Qiagen), of which 1 μg RNA was processed using Illumina TruSeq RNAseq Sample Preparation kit v2 (Cat# RS-122–2001) to generate libraries. Library quality was verified using the Bioanalyzer DNA 1000 assay (Agilent Technologies), and sequencing was performed using the Illumina HiSeq 2000 system with single read (1 × 50 bp) option. Reads were processed using TopHat2 (version 2.0.16) (35, 36) and Cufflinks (version 2.2.0) (37) programs with the Tuxedo protocol (38) for alignment of short reads, transcript assembly, and analysis of differential expression. On average, there were ∼13 million reads per sample, with >11,600 genes quantified at each time point with an acceptable quality by Cufflinks. Genes were quantified only when fragment per kilobase of transcript per million mapped fragments (FPKM) were greater than or equal to one under two conditions (e.g. miR-22 and NT).

RESULTS

Protein Abundance Changes in Response to miR-22

WM239A cells derived from metastatic melanoma were labeled by SILAC with heavy (H) or light (L) isotopically-labeled Arg+Lys, and transfected with 50 nm of nontargeting (NT) miRNA or miR-22, previously identified as an miRNA whose expression is regulated by oncogenic mutant B-Raf signaling in melanoma (39). Proteins from whole cell lysate were trypsinized and the resulting peptides were analyzed by LC-MS/MS (Fig. 1A). Using a 2D-UPLC RP–RP LTQ-Orbitrap configuration with step gradient elutions in the first dimension followed by linear gradient elution in the second dimension, more than 4000 proteins were typically quantified after 56 h of data collection (supplemental Table S1).

Fig. 1.

Fig. 1.

SILAC-based proteomics allows accurate and reproducible protein quantification. A, Diagram of the SILAC experiment. Proteins in WM239A cells were metabolically labeled with heavy (Arg+Lys) or light (Arg+Lys). Cells were transfected with 50 nm miR-22 (H) or 50 nm nontargeting (NT) control (L), harvested at 48 h, and processed as described in Materials and Methods. Tryptic peptides were resolved by 2D-RP-RP-UPLC and were identified by MS/MS. B, Plot comparing log2 (protein ratio) showed strong correlation (Pearson's r = 0.73) between values normalized by transfection with NT or no miRNA (mock). The two experiments quantified 4762 proteins of which 3225 were quantified in both experiments. C, Plot comparing log2 (protein ratio) showed good agreement (r = 0.86) between experiments where miR-22- and NT-transfected cells were reversely labeled. The two experiments quantified 5295 proteins of which 3918 were quantified in both experiments. D, Plot comparing log2 (protein ratio) showed good agreement (r = 0.83) between biological duplicate experiments (i.e. separate cell passages). We quantified 5253 proteins in two experiments and 3561 in both experiments. E, Histogram showing the distribution of the difference from the mean log2 (protein ratio), comparing the biological duplicate experiments in D. 99% of measurements were within log2 (difference from mean) < 0.3 (red lines), from which protein changes of log2(miR-22/NT) > 0.3 were accepted as significant with 1% false discovery rate. F, Cumulative distribution showing proteins with transcripts with 8mer seed matching sequence (red), 7mer m8 (blue), 7mer A1 (cyan), 6mer only (green), or no site (black).

Log2 (protein ratio) normalized to nontargeting (NT) miRNA versus no miRNA (mock) showed good correlation (Fig. 1B, Pearson's r = 0.73), indicating similarity between different control conditions. Therefore, only NT was used as the control in further experiments. Protein ratios were in good agreement when miR-22- and NT-transfected cells were reversely labeled (Fig. 1C, r = 0.86), or when protein ratios were measured in biological duplicate experiments (Fig. 1D, r = 0.83). This supported reproducibility with no bias introduced by labeling order. Based on comparisons between duplicate experiments, protein ratios corresponding to log2(miR-22/NT) > 0.3 were accepted as significant with 1% false discovery rate (Fig. 1E). Of 3444 proteins quantified reproducibly, 350 were significantly up-regulated and 400 down-regulated in response to miR-22. Ninety percent of the significant protein changes showed ratios less than 2-fold, consistent with previous proteomics analyses of miRNA responses (27, 4044). Thus, protein ratio measurements were accurate and reproducible, and enabled quantification of 1.23-fold changes in proteins responsive to miR-22.

Classifications of mRNA seed matching sequences included: seed-matches to miRNA positions 2–8 with adenosine at target position 1 (8mer); seed-matches to miRNA positions 2–8 (7mer m8); seed-matches to miRNA positions 2–7 plus adenosine at target position 1 (7mer A1); and seed-matches to miRNA positions 2–7 (6mer) (19, 45, 46). Genomics and proteomics studies have shown that proteins corresponding to mRNAs with at least one 7mer or 8mer matching sequence within the 3′UTR are most strongly repressed by miRNAs (40, 46). We observed the same behavior in response to miR-22 (Fig. 1F). In total, 156 proteins were both responsive to miR-22 and corresponded to mRNAs containing at least one 7mer or 8mer seed-matching sequence, and can be considered primary targets. They are referred to as “seed-matches” and are the focus of this study.

miRNA Target Prediction Algorithms

We examined the degree to which different methods predicted the targets of miR-22 that we identified by proteomics. Of the proteins observed in biological duplicates, 534 corresponded to mRNAs containing seed-matching sequences (8mer or any 7mer), of which 156 were significantly repressed by miR-22 (Fig. 2A). The remaining 378 proteins were unaffected, providing an estimate of 71% false positives predicted based on seed-matching sequence alone. Of the 400 proteins that were significantly down-regulated, 244 (61%) lacked corresponding mRNA seed-matching sequences, suggesting that they are regulated indirectly. Cumulative distribution plots showed greater fold-changes in proteins corresponding to mRNAs with 8mer or 7mer seed-matches, compared with proteins with no seed-match (p < 10−6, one-sided Mann-Whitney U test, “M-W”) (Fig. 2B).

The primary targets were then used to analyze predictions by different algorithms, each applied using their default cutoffs and/or stringency thresholds. miRanda (http://www.microrna.org) combines evolutionary conservation of seed-matching sequences and calculated binding energies for miRNA–mRNA interactions with a flexible algorithm for sequence complementary and position within mRNA 3′UTR or coding sequences (16, 17). The predicted targets include those with imperfect base pairing between seed:seed-matching sequences. Of the proteins that were quantified by proteomics, miRanda predicted 259 as miR-22 targets. Of these, 96 were down-regulated at the protein level, yielding 163 (63%) estimated false positives (Fig. 2C). Of the 156 primary targets, 69 were excluded by miRanda, yielding 44% false negatives. We then filtered predicted targets according to the presence of 8mer or 7mer seed matching sequences within corresponding transcripts. A subset of 194 miRanda-predicted targets had perfect 3′ UTR seed matches, of which 87 were down-regulated, indicating 107 (55%) false positives. In contrast, 65 miRanda-predicted targets had 6mer sequences, imperfect seed base-pairing, and/or were located outside of the 3′UTR. Of these, only nine were down-regulated, indicating higher (86%) false-positives in this category. Cumulative distributions were comparable between all miRanda-predicted targets, the subset with perfect base-pairing, and targets predicted solely based on seed-matching sequences (Fig. 2D), suggesting that miRanda performs comparably with predictions based on seed-matching sequence alone.

Targetscan (http://targetscan.org) uses a model for site efficacy based on correlations between target repression and various sequence “contexts” (e.g. additional base pairing in the miRNA 3′ region, local AU content, and position within the 3′ UTR), as well as evolutionary conservation of 3′UTR seed matching sequences (19, 20). Targetscan predicted 69 proteins as miR-22 targets (Fig. 2E), of which 36 were down-regulated at the protein level, yielding 33 (48%) false positives. Of 156 primary targets, 120 were excluded by Targetscan, yielding 77% false negatives. Targetscan-predicted proteins showed stronger fold-repression compared with those predicted solely by seed-matching sequence (Fig. 2F), showing that the algorithm filters targets with low magnitude fold-change while accepting higher numbers of false negatives.

The Probability of Interaction by Target Accessibility (PITA) algorithm evaluates the net free energy of miRNA-target interactions (ΔΔG), calculated as the difference between the free energy gain from miRNA–mRNA hybridization (ΔGduplex) minus the free energy loss from 3′UTR secondary structure melting (ΔGopen) (21). PITA predicted 52 proteins as miR-22 targets (Fig. 2G), of which 28 were down-regulated at the protein level, yielding 24 (46%) false positives. Of the 156 primary targets, 128 were excluded by PITA, yielding 82% false negatives. Fold-changes in protein repression were higher among PITA-predicted proteins compared with those predicted solely from seed-matching sequence (Fig. 2H). Thus, PITA and Targetscan both filter targets with low magnitude fold-changes at the expense of high false negatives. In total, miRanda, PITA, and Targetscan identified 110 primary targets, of which only 13 were predicted by all algorithms. Approximately 50% of primary targets identified by Targetscan overlapped with targets identified by PITA and vice versa, whereas ∼25% of targets identified by miRanda overlapped with either PITA or Targetscan (supplemental Fig. S1). Estimates of false positives and false negatives identified by each program are summarized in Table I.

Table I. Summary of performance of miRNA target prediction algorithms. Primary targets of miR-22 are those proteins down-regulated by miR-22, with 3′UTR transcripts containing 7mer or 8mer seed matching sequences.
Prediction program True positives False positives False negatives
Seed matching sequence 156 378 (71%)
miRanda 87a 163 (63%) 69 (44%)
Targetscan 36 33 (48%) 120 (77%)
PITA 28 24 (46%) 128 (82%)

a miRanda predicted an additional 56 proteins as potential targets, which had imperfect base-pairing within seed-matching sequence. Of these, nine were down-regulated by miR-22. These miRanda-predicted targets were excluded from the number of true positives.

miRNA responses were then correlated with scores evaluated by prediction algorithms. Fig. 2I shows small but significant correlations (Pearson's r = −0.32, p < 10−6) between log2 (protein ratio) and the Targetscan “probability of preferentially conserved targeting score (PCT),” which calculates a Bayesian estimate of the probability that a seed-match is conserved because of selective pressure during evolution (20). Correlations were also seen (r = 0.34, p < 10−6) with the Targetscan “context score,” which estimates seed-match efficacy based on features of the 3′UTR (seed-match type contribution, base-pairing with miRNA 3′ sequences, local AU content, and position within the 3′UTR), regardless of sequence conservation (19). In contrast, Fig. 2J shows low correlation between protein ratio and the PITA-calculated net free energy of miRNA-target interaction (ΔΔG; r = −0.11, p = 0.04), which reflects the free energy gain from miRNA–mRNA hybridization (ΔGduplex; r = −0.01, p = 0.88) minus the free energy of transcript 3′UTR folding (ΔGopen; r = −0.13, p = 0.02). This reflects a bias of Targetscan but not PITA for predicting targets with higher fold-changes.

Variations in Sensitivity to miRNA Concentration

We asked whether primary targets showed biases in their sensitivity to exogenous miRNA, by monitoring the dose-response of protein ratios with varying miRNA concentrations. Cells were transfected with 10, 25, 50, or 100 nm miR-22 or NT and harvested 48 h post-transfection. Levels of intracellular miR-22 increased linearly with the concentration of transfected miRNA, reaching up to 42,000 copies/pg at 50 nm miR-22 (supplemental Fig. S2), an amount comparable to physiological levels of other miRNAs (47, 48). Plots comparing log2 (protein ratios) showed strong correlations between experiments at different miR-22 concentrations (Pearson's r = 0.77–0.88) (Fig. 3A). However, an unexpected discontinuity was observed, where the slope of the correlation plots equaled ≈1 when comparing 10 nm versus 25 nm or 50 nm versus 100 nm (Fig. 3A, left and right panels, respectively), but increased to ≈1.8 when comparing 25 nm versus 50 nm (Fig. 3A, middle panel). This indicates that a transition occurs above 25 nm and below 50 nm, which increases the magnitude of protein ratios. The transition between 25 and 50 nm was also apparent in plots of cumulative distribution versus log2 (protein ratio), for the subset of proteins corresponding to mRNAs with 8mer or 7mer seed-matches (Fig. 2B). Thus, primary targets show discontinuous responses to miRNA concentration, in parallel with those seen proteome-wide.

Fig. 3.

Fig. 3.

Primary targets vary in their sensitivity to miRNA concentration. A, Plots comparing log2 (protein ratio) from cells transfected with 10 nm versus 25 nm (left panel), 25 nm versus 50 nm (middle panel), and 50 nm versus 100 nm (right panel). Red line represents slope = 1. B, Cumulative distribution of log2 (protein ratio) for seed-matches at 10 nm (black), 25 nm (blue), 50 nm (orange), and 100 nm (red) miR-22. C, Dose-response curves for 138 primary targets, classified by the miRNA concentration at which repression reaches the significance threshold of log2 (protein ratio)< −0.3 (horizontal red line). D, Primary targets repressed at 10 nm showed two patterns, one where repression was maximal at 10 nm and where repression plateaued up to 25 nm followed by further repression above 50 nm. Colors for individual proteins in D were matched to those in C. E, Targetscan PCT (left panel) or context scores (right panel), plotted for those primary targets classified as more sensitive (repressed at 10 nm miR-22) or less sensitive (repressed at 50–100 nm miR-22). Box and whisker plots show median values (red bar), the first and third quartiles (upper and lower box limits), maximum 1.5-fold of interquartile range (whisker), and outliers (red points). F, PITA-calculated free energies (ΔΔG, ΔGduplex, and ΔGopen) plotted for primary targets classified as more or less sensitive. p values were calculated by M-W test. “n.s.” = non-significant.

We focused on 137 of the 156 primary seed-matched targets, excluding those with larger errors. Proteins were classified by the miRNA concentration at which repression reached the significance threshold of log2 (protein ratio) < −0.3 (Fig. 3C), yielding 49 (36%), 10 (7%), 50 (37%), and 28 (20%) proteins repressed at 10, 25, 50, and 100 nm, respectively. Similar numbers of targets were responsive within the more sensitive (10 nm) and less sensitive (50 and 100 nm) groups, whereas fewer targets were responsive with intermediate sensitivity (25 nm). Different dose response patterns were observed in the more sensitive group, where half of the proteins showed maximal repression at 10 nm, whereas the other half reached a plateau between 10–25 nm followed by further repression above 25 nm (Fig. 3D). Thus, the analysis revealed an unexpected bimodality with respect to the dose response behavior of primary miRNA targets.

Primary targets classified with greater or less sensitivity to miRNA concentration were then examined for correlations with prediction scores. Targets with greater sensitivity (i.e. repressed at 10 nm miR-22) showed significantly higher PCT (p < 0.002, M-W) and context scores (p < 0.003) than targets with less sensitivity (repressed at 50–100 nm) (Fig. 3E). Sensitive targets were also correlated with the net free energy for miRNA-target binding (ΔΔG; p < 0.02), which was inversely correlated with the free energy of 3′UTR folding (ΔGopen; p < 0.003), and uncorrelated with the free energy of miRNA:mRNA binding (ΔGduplex; p = 0.30) (Fig. 3F). This reveals an energetic basis underlying bimodality, and indicates that Targetscan and PITA scores favor targets responding with higher sensitivity to exogeneous miRNA.

Variation in Kinetics of Target Repression

Pulsed SILAC (pSILAC) was used to examine the kinetics of primary target repression on a proteome-wide scale (27). Here, cell labeling began at the onset of miR-22 treatment so that only newly synthesized proteins were labeled (Fig. 4A) in contrast to SILAC, where proteins were labeled prior to treatment (Fig. 1A). Measurements between pSILAC versus parallel SILAC experiments were strongly correlated (r = 0.96; Fig. 4B), indicating comparable abilities of the two methods to report protein changes. This argues that previously unexplained discrepancies in the literature that showed poor correlations (r = 0.3) between seed-matched proteins responsive to miR-1 in HeLa cells (27, 40), were not caused by the different labeling methods used in the two studies. However, the slope of the plot ≈1.2 (R2 = 0.89) indicating that pSILAC reports higher protein ratios compared with SILAC, which can be attributed to the lower background of newly synthesized proteins quantified by pSILAC.

Fig. 4.

Fig. 4.

Primary targets vary in their kinetics of repression. A, Diagram of the pSILAC experiment. Unlabeled cells were switched into heavy or medium media, followed by transfection with 50 nm miR-22 or control NT, respectively, for 12, 18, 24, 36, or 48 h. B, Plot comparing log2(protein ratio) measured by pSILAC versus SILAC treated cells, in both cases transfected for 48 h. Each log2(protein ratio) corresponds to the mean from biological duplicate experiments. Red line represents slope = 1. The slope estimated by linear regression = 1.2. C, Plots comparing log2(protein ratio) for each time point (y axis) to 48 h (x axis). Red lines represent slope = 1. D, Time courses for 95 primary targets, classified by the time at which repression reaches the significance threshold of log2(protein ratio) < −0.3 (horizontal red line). E, Box and whisker plot comparing the half-lives for proteins classified as primary targets with early (repressed at 12–24 h) versus late (repressed at 36–48 h) responses. p values were calculated by the M-W test. F, Box and whisker plots comparing Targetscan PCT (left panel) and context score (right panel) for primary targets classified as early versus late response. G, PITA-calculated free energies for primary targets classified as early or late responses. H, Box and whisker plot comparing the distribution of log2 (protein ratio) for primary targets, classified by the time (x axis) and miR-22 concentration (colors) at which the targets are significantly repressed. Log2 (protein ratio) measurements are from 48 h data sets.

We examined how rapidly proteins responded to miR-22 on a proteome-wide scale. Cells were transfected with 50 nm miR-22 or NT, then harvested at 12, 18, 24, 36, and 48 h. Among 4733 quantifiable proteins in total, 1842 (39%) were quantifiable at all five time points. Log2 (protein ratio) measured at 12 versus 48 h were correlated with slope = 0.22 (r = 0.52), reflecting smaller responses at 12 h compared with 48 h (Fig. 4C). In contrast, log2 (protein ratio) at 36 versus 48 h were correlated with slope = 0.94 (r = 0.95), indicating that the changes in newly synthesized proteins reached steady-state by 36 h. Thus, fewer than 5% of proteins (85 of 1842) responded at 12 h, whereas 25% (449 of 1842) responded significantly by 48 h. Of the 156 primary targets, 95 proteins were quantifiable across the time course, of which 21, 20, 9, 24, and 21 reached the significance threshold at 12, 18, 24, 36, and 48 h, respectively (Fig. 4D). Thus, primary targets were distributed across the time course, with similar numbers responding at early (<18 h) versus late (>36 h) times, with half the number responding at intermediate times (24 h).

We asked whether differential protein turnover might explain the differences in kinetics, where targets undergoing faster turnover might be down-regulated more rapidly than those undergoing slower turnover. To address this, protein half-lives were measured proteome-wide by pulse-labeling cells for 24 h with heavy Arg+Lys. Assuming first-order decay, half-lives were quantified for 1804 proteins, with ≤ 20% error in at least two of three biological replicate experiments (supplemental Table S2). All half-lives measured were long (median t1/2 = 112 h), and primary targets repressed early (12–18 h) indeed showed significantly shorter half-lives (median t1/2 = 107 h) than those repressed at later times (36–48 h; median t1/2 = 140 h) (Fig. 4E; p < 0.02, M-W). However, the median t1/2 values for the primary targets in the two categories (107 h and 140 h) were too long to explain the difference in kinetics of protein repression on the timescale of 12–48 h, indicating that variations in protein turnover are not likely to be the main cause of the variable kinetics of target repression.

Targets repressed at early versus late times were examined for correlations with PCT, context score, and free energy. Interestingly, targets responding early showed significantly higher PCT (p < 0.0003, M-W) and context score (p < 0.0004, M-W) than targets responding later (Fig. 4F). Likewise, targets responding early showed significantly higher ΔΔG (p < 0.0002) and ΔGduplex (p < 0.04) as well as lower ΔGopen (p < 0.0007) (Fig. 4G). Thus, parameters related to seed sequence matching and surrounding features, seed sequence conservation, and stability of miRNA–mRNA and 3′UTR secondary structure stability, all contribute toward distinguishing the varying kinetics of miRNA responses.

Next, we examined relationships between target sensitivity to miRNA, the kinetics of repression, and variations in log2 (miR-22/NT) (Fig. 4H). Targets repressed at 10 nm showed higher protein fold changes as well as a preferential association with early response times. In contrast, targets repressed at 50–100 nm responded at both early and late times, with comparable protein ratios across all time points. The results indicate that primary targets with highest sensitivity to miRNA concentration are down-regulated more rapidly, whereas the remaining targets show little correlation between sensitivity, kinetics, and fold-change.

Primary Targeted Proteins versus mRNA

Finally, we examined variations in repression at the mRNA level. Cells were transfected with 50 nm miR-22 or NT and harvested at 12, 18, 24, 36, and 48 h, followed by transcript sequencing and quantification by RNAseq. Among 12,023 genes quantifiable with FPKM greater than 1, as many as 11,088 were quantifiable across all five time points (Table S3). Weak correlations were observed between log2 (mRNA ratio) measured at 12 versus 48 h (slope = 0.39, r = 0.25), in contrast to strong correlations between 36 versus 48 h (slope = 0.85, r = 0.75) (Fig. 5A). Thus, mRNA responses were small at 12 h and reached steady state by 36 h, as observed at the protein level. mRNAs with 3′UTR seed-matches were then selected and sorted based on the time at which they reached a significance threshold of log2 (miR-22/NT) < −0.3 (Fig. 5B). In total, 617 transcripts containing 8mer or 7mer seed-matches were down-regulated, of which 283, 99, 47, 131, and 57 genes were repressed at 12, 18, 24, 36, and 48 h, respectively. Thus, like proteins, significant numbers of primary targets responded at early (12–18 h) or late (>36 h) times, but fewer responded at intermediate times (24 h).

Fig. 5.

Fig. 5.

mRNA transcript quantification of miRNA targets. A, Scatter plots comparing log2 (mRNA ratio) quantified by RNAseq, from cells transfected with 50 nm of miR-22 or NT. Data from each time point (y axis) is compared with 48 h (x axis). B, Time courses for transcripts containing at least one 3′UTR 8mer or 7mer, classified by the time at which the target mRNA repression reaches log2 (mRNA ratio) < −0.3. C, Scatter plots comparing log2 (mRNA ratio) and corresponding log2 (protein ratio) at each time point. D, Time course for representative primary targets, classified by mRNA repression preceding (left panel), concomitant (middle panel), or following (right panel) protein repression. The full set of 93 targets is shown in Supplemental Fig. S3. E, Box and whisker plots of Targetscan PCT score (left panel) or context score (right panel) for mRNAs classified as early (repressed at 12–24 h) versus late (repressed at 36–48 h) responses. F, PITA-calculated free energies for primary target transcripts classified as early or late responses. G, Box and whisker plots comparing distributions of mRNA abundance (FPKM from 48 h data sets) for primary targets classified as more (10 nm) versus less (50–100 nm) sensitive responses, and by early (12–24 h) versus late (36–48 h) responses.

Plots of mRNA versus protein ratios were correlated at all time points (r = 0.43–0.76), with slope greater than 1 between 12–24 h and approximately equal to 1 at 36–48 h (Fig. 5C). Thus, at earlier time points, mRNA ratios exceeded their corresponding protein ratios, whereas at steady state, the ratios closely matched. This suggests that genome-wide, mRNA repression generally precedes protein repression. Time courses for mRNAs and corresponding proteins were compared for primary targets, including 93 of the 95 protein targets shown in Fig. 4D that were quantifiable at the transcript level (Fig. 5D, supplemental Fig. S3). Of these, mRNA down-regulation preceded or occurred concurrently with protein down-regulation in 87 (94%) cases (Fig. 5D, left and middle panels), whereas protein changes preceded mRNA changes in six (6%) cases (Fig. 5D, right panel). Overall, the majority of protein responses to miR-22 occurred concomitantly with responses of mRNA destabilization and decay, while few but finite numbers reflected predominant protein responses.

Next, we examined early versus late transcript responses for correlations with PCT, context score, and free energy. As observed with proteins, primary target mRNAs that responded early showed significantly higher PCT (p < 10−6) and context score (p < 10−6) (Fig. 5E). Like early proteins, early mRNA targets showed significantly higher ΔΔG (p < 3 × 10−6) and lower ΔGopen (p < 10−6) compared with later targets (Fig. 5F), whereas ΔGduplex showed little correlation (p = 0.32). Taken together, global effects on mRNA measured by RNAseq recapitulated the kinetic behavior of proteins measured by the proteome-wide screen, with similar physical features distinguishing early versus late targets.

Analyses of miRNA reporters have suggested that target repression depends on a balance between cellular concentrations of miRNA and mRNA, where stronger repression occurs when mRNA targets are expressed at low abundance (12). We tested the hypothesis that targets responding with higher sensitivity and/or at earlier times might reflect lower copy number transcripts where higher repression efficacy might be expected. Transcript abundances were quantified by FKPM and correlated against primary targets that varied with respect to kinetics and dose responses. For targets responding at early times, the median transcript abundance was higher than for targets responding at later times (Fig. 5G, p = 0.07). Likewise, for targets responding with higher sensitivity to miRNA, the median transcript abundance was greater than targets responding with less sensitivity (Fig. 5G, p = 0.07). Therefore, the trends in each case reflected higher transcript abundance among the targets with greater sensitivity to miRNA and earlier responses, contradicting our initial prediction.

DISCUSSION

Our study represents the first proteome-wide analysis of primary miRNA responses as a function of treatment time and concentration. Primary targets were identified based on the criteria that 1) they are down-regulated in response to miR-22, and 2) their mRNA 3′UTRs contain 8mer or 7mer seed-matches. We observe significant and unexpectedly large differences in the response thresholds of primary targets with respect to time and concentration. A key finding is that variations in threshold appear bimodal, with greater numbers of proteins repressed at low (10 nm) and high (50–100 nm) exogenous miRNA, compared with an intermediate (25 nm) concentration. Primary targets also show variable thresholds for the onset of repression, showing greater numbers with rapid (12–18 h) or slow (36–48 h) kinetics, compared with intermediate (24 h) times. Similar behavior is seen at the transcript level. Proteins responding to low miRNA concentration also showed two distinct patterns, one where repression was maximal at 10 nm, and another where repression plateaued at 10–25 nm and then increased further above 50 nm. Our results expand the understanding of miRNA target repression, by revealing heterogeneity in mechanisms that reflect distinct features of transcript sequences, and modulate thresholds in sensitivity and timing of protein responses.

Although the explicit mechanisms are unknown, certain possibilities can be eliminated. Our initial hypothesis was that rapid versus delayed repression may reflect proteins with shorter versus longer half-lives, respectively. This was clearly not supported by pulse-chase proteomics experiments, because nearly all proteins showed half-lives that were longer than the early versus late timescale of repression. We conclude that variable kinetics are better explained by differences in rates of translational repression and/or mRNA decay. Likewise, transcript abundance measurements lent no support to the hypothesis that transcripts found in low copy number are more sensitive to miRNAs. Furthermore, no bias was observed either in the number or the type of seed sequence sites, when comparing high versus low sensitivity, or fast versus slow responses (supplemental Fig. S4). This argues against models where repression mechanisms differ by the number of miRISC complexes that can bind to a single target transcript.

Both the kinetics and dose responses of protein and mRNA changes turned out to be most strongly correlated with ΔΔG, the net free energy of miRNA-target interactions, which mainly reflected inverse correlations with ΔGopen, the free energy of forming secondary structure at or nearby the miR-22 seed sequence sites. Thus, our working model is that variability somehow reflects stabilization of secondary structures within the 3′UTR, which in turn interferes with the accessibility of miRISC to seed matching sequences, blocking miRNA–mRNA hybridization. The heterogeneity in concentration dependence between different transcripts means that relevant binding sites are not all saturated at low concentrations of miR-22. More sensitive targets – i.e. those responding to 10 nm miR-22 – responded with faster kinetics, suggesting that one mode of repression reflects facile interactions with target sites and rapid responses. In contrast, the less sensitive targets are equally distributed between fast and slow kinetics, suggesting that energetic barriers to unfolding shift the threshold for saturation to higher concentrations, but are not rate-limiting.

Varying thresholds for saturation imply mechanisms involving competition for miRNA binding sites. For example, proteins binding to 3′UTR regulatory elements at or near the seed sequence site might compete for miRISC binding. This has been observed in several systems where RNA binding proteins (RNPs) compete for miRNA binding sites (4952). Alternatively, proteins may indirectly perturb transcript secondary structure, as in the case of HuR, an RNP which, in response to cell stress, reverses miRNA-mediated repression by oligomerizing in complex with 3′UTR sequences at a distance from the seed sequence site (53, 54). Thus, the observed gap in concentration threshold might be explained if RNP interference is weak toward targets with high miRNA–mRNA affinity, leading to faster and more sensitive responses to miRNAs, but efficient toward targets with lower affinity, requiring higher miRNA concentrations or longer times, enough to compete for binding. Other mechanisms involving competing miRNA sites within the cell might also create gaps by increasing the threshold for miRISC binding to lower affinity transcripts (55, 56). Our findings provide evidence for the potential involvement of cellular factors that separate miRNA targets into distinct classes with respect to timing and sensitivity.

Intriguingly, we found a set of transcripts that were down-regulated at 10 nm, reached a plateau between 10–25 nm, and were further down-regulated above 50 nm miRNA. This might be explained by the presence of multiple sites within 3′UTRs with varying affinities, which lead to different concentration thresholds for the entire population of each transcript. However, inspection of these transcripts showed no differences from others in numbers or types of seed sequence sites (not shown), arguing against this model. A more likely explanation is that certain transcripts are heterogeneous within each population, with respect to their ability to function as miRNA targets. This could reflect transcript isoforms such as alternative splice variants, or else variations in structure that lead to heterogeneity in RNP interactions and interference with binding at low miRNA concentrations. The finding predicts that certain transcripts will show graded responses in sensitivity and fold-change, under cellular conditions that lead to varying steady state miRNA levels.

The mechanism for miRNA repression involves miRISC-GW182-PABC recruitment of enzymes catalyzing deadenylation, 5′decapping, and exonuclease-catalyzed degradation of mRNA, as well as sequestration of eukaryotic initiation factors leading to translational repression (7, 57). Current models cannot readily distinguish between mechanisms involving protein loss primarily caused by mRNA decay, versus situations where mRNA decay and translational repression occur independently. In principle, both processes could be strongly coupled, whereby triggering the same repression/decay mechanism induces both processes, which are biased toward loss of protein versus mRNA depending on cellular conditions. Thus, it was interesting that we observed three types of patterns when comparing the kinetics of mRNA versus protein repression. The overwhelmingly largest numbers of cases (77, 84%) were consistent with strong coupling between mRNA and protein regulation, showing mRNA decay occurring concomitantly with protein down-regulation. Only 10 cases showed mRNA preceding protein down-regulation (BTF3, CLCN7, EPB41L2, GBA, GNPDA1, MAP1B, PTGFRN, PURB, STX4, and TACC1, supplemental Fig. S3), while two cases showed mRNA following protein down-regulation (MYO5A and RBM17, supplemental Fig. S3). In four cases, proteins were down-regulated with no evidence for loss of mRNA (GLG1, GNAS, SPARC, and SYNE2, Fig. 5D, supplemental Fig. S3). Our findings reveal heterogeneity in protein versus mRNA repression mechanisms, which may be useful for identifying features of transcripts that influence the repression mechanism. Our findings differ from those in recent studies in Drosophila S2 cells and zebrafish embryos, where translational repression appears to be the dominant mechanism for miRNA-mediated protein repression (58, 59). This could be caused by species differences and/or differences in timing (e.g. 6–12 h in zebrafish). In any case, our observations suggest that once mRNA degradation starts, it becomes the dominant mechanism in mammalian cells. The primary target set revealed substantive differences between prediction algorithms (Table I). On one hand, miRanda predicted 259 targets, of which 63% were false positives and 44% were false negatives. On the other hand, TargetScan predicted only 69 targets, which decreased the false positives to 48% but increased false negatives to 77%. Likewise, PITA predicted 52 targets, yielding 46% false positives and 82% false negatives. The proteins identified by Targetscan overlapped those identified by PITA by ∼50%, indicating greater similarity in performance between these algorithms compared with miRanda, where the overlap was only ∼25% (supplemental Fig. S1). This reveals partial interdependence between sequence context and evolutionary conservation features evaluated by Targetscan and the free energy of miRNA–mRNA hybridization evaluated by PITA.

As in previous reports (27, 4044), the responses to miRNA reflected mild repression at the protein level, ranging from 1.25- to 4-fold. The magnitude of protein fold-changes, which is often used to evaluate efficacy, correlated well with seed matching sequence classification, PCT, and context scores. To some extent, such correlations reflect biases in the methods used to develop the scores. For example, context scores were developed from transcript microarray measurements assayed 12–24 h post-transfection (19), and therefore might be expected to favor targets that respond earlier, whereas excluding primary targets that respond more slowly. Likewise, PITA is optimized based on luciferase expression responses to endogenous miRNAs, measured 20 h after transfection of reporter plasmid. The bias in prediction programs toward early responses could be observed within the set of 156 primary targets, which showed that although the majority of Targetscan- or PITA-predicted targets mostly responded at early times (12–24 h), targets missed by these programs (false negatives) were more equally represented at early and late times (supplement Fig. S5). Proteins may show larger fold-change because they reflect targets that respond earlier or with higher sensitivity, whereas additional repression might be observable if experimental conditions were extended to longer times and higher concentrations. Viewed in this way, variations in fold-changes may partially reflect the heterogeneity in mechanisms affecting kinetics and dose response among primary targets. An implication of our study is that important targets that respond late or at high concentrations may be underestimated when efficacy is evaluated based on fold-change or scores that are correlated with magnitude of responses.

In summary, our study documents heterogeneity in primary targets of a single miRNA, predicting that in a normal biological context, waves of target responses may occur with respect to kinetics and concentration that vary depending on cellular state. Estimates of miRNA half-life range from 1 to >200 h in animal cells (6062), arguing that targets with extended kinetics are likely to be biologically relevant. In addition, measurements of intracellular miRNA concentrations show 60- to 250-fold increases in response to transfection of 15–50 nm exogenous miRNA (39, 63, 64), matching the more than 1000-fold changes in endogenous miRNAs quantified under varying cellular (e.g. disease) conditions (65, 66). This argues that miRNA responses cover a dynamic range that includes a wide range of exogenous miRNA concentrations. We propose that primary targets that respond late and with lower sensitivity, although often excluded from analysis, are important to consider as physiological regulators of miRNA-controlled processes. It will be important to compare our findings with miR-22 against other miRNAs, to see whether miRNAs behave differently with respect to dose-response and kinetics of target repression.

Supplementary Material

Supplemental Data

Acknowledgments

We thank Roy Parker and Rui Yi (U. Colorado, Boulder) for critical reading of the manuscript and many valuable discussions, and to Emily Anderson (Dharmacon) for collaborative interactions that initiated our investigations into miRNA biology.

Footnotes

Author contributions: T.L. and N.A. designed research; T.L., N.W., S.H., and K.C. performed research; T.L., W.O., and N.A. analyzed data; T.L., N.W., and N.A. wrote the paper.

* This work was supported by NIH grant R01 CA118972 (N.G.A.).

1 The abbreviations used are:

miRNA
microRNA
miRISC
miRNA-mediated silencing complex
3′UTR
3′untranslated region
SILAC
stable isotope labeling by amino acid in cell culture
pSILAC
pulsed SILAC
M-W
one-sided Mann-Whitney U test
FPKM
Fragments Per Kilobase of exon per Million fragments mapped.

REFERENCES

  • 1. Bartel D. P. (2009) MicroRNAs: target recognition and regulatory functions. Cell 136, 215–233 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Yi R., Poy M. N., Stoffel M., Fuchs E. (2008) A skin microRNA promotes differentiation by repressing “stemness.” Nature 452, 225–229 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Chen J.-F., Mandel E. M., Thomson J. M., Wu Q., Callis T. E., Hammond S. M., Conlon F. L., Wang D.-Z. (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 38, 228–233 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Rottiers V., Näär A. M. (2012) MicroRNAs in metabolism and metabolic disorders. Nat. Rev. Mol. Cell Biol. 13, 239–250 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Thum T., Gross C., Fiedler J., Fischer T., Kissler S., Bussen M., Galuppo P., Just S., Rottbauer W., Frantz S., Castoldi M., Soutschek J., Koteliansky V., Rosenwald A., Basson M. A., Licht J. D., Pena J. T. R., Rouhanifard S. H., Muckenthaler M. U., Tuschl T., Martin G. R., Bauersachs J., Engelhardt S. (2008) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signaling in fibroblasts. Nature 456, 980–984 [DOI] [PubMed] [Google Scholar]
  • 6. Carthew R. W., Sontheimer E. J. (2009) Origins and mechanisms of miRNAs and siRNAs. Cell 136, 642–655 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Huntzinger E., Izaurralde E. (2011) Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat. Rev. Genet. 12, 99–110 [DOI] [PubMed] [Google Scholar]
  • 8. Behm-Ansmant I., Rehwinkel J., Doerks T., Stark A., Bork P., Izaurralde E. (2006) mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes. Genes Dev. 20, 1885–1898 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Fabian M. R., Mathonnet G., Sundermeier T., Mathys H., Zipprich J. T., Svitkin Y. V., Rivas F., Jinek M., Wohlschlegel J., Doudna J. A., Chen C.-Y. A., Shyu A.-B., Yates J. R., III, Hannon G. J., Filipowicz W., Duchaine T. F., Sonenberg N. (2009) Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation. Mol. Cell 35, 868–880 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Rehwinkel J., Behm-Ansmant I., Gatfield D., Izaurralde E. (2005) A crucial role for GW182 and the DCP1:DCP2 decapping complex in miRNA-mediated gene silencing. RNA 11, 1640–1647 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Chendrimada T. P., Finn K. J., Ji X., Baillat D., Gregory R. I., Liebhaber S. A., Pasquinelli A. E., Shiekhattar R. (2007) MicroRNA silencing through RISC recruitment of eIF6. Nature 447, 823–828 [DOI] [PubMed] [Google Scholar]
  • 12. Mukherji S., Ebert M. S., Zheng G. X. Y., Tsang J. S., Sharp P. A., van Oudenaarden A. (2011) MicroRNAs can generate thresholds in target gene expression. Nat. Genet. 43, 854–859 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Ebert M. S., Sharp P. A. (2012) Roles for microRNAs in conferring robustness to biological processes. Cell 149, 515–524 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Li X., Cassidy J. J., Reinke C. A., Fischboeck S., Carthew R. W. (2009) A microRNA imparts robustness against environmental fluctuation during development. Cell 137, 273–282 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Stark A., Brennecke J., Bushati N., Russell R. B., Cohen S. M. (2005) Animal microRNAs confer robustness to gene expression and have a significant impact on 3′UTR evolution. Cell 123, 1133–1146 [DOI] [PubMed] [Google Scholar]
  • 16. Enright A. J., John B., Gaul U., Tuschl T., Sander C., Marks D. S. (2003) MicroRNA targets in Drosophila. Genome Biol. 5, R1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. John B., Enright A. J., Aravin A., Tuschl T., Sander C., Marks D. S. (2004) Human microRNA targets. PLoS Biol. 2, e363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Krek A., Grün D., Poy M. N., Wolf R., Rosenberg L., Epstein E. J., MacMenamin P., da Piedade I., Gunsalus K. C., Stoffel M., Rajewsky N. (2005) Combinatorial microRNA target predictions. Nat. Genet. 37, 495–500 [DOI] [PubMed] [Google Scholar]
  • 19. Grimson A., Farh K. K.-H., Johnston W. K., Garrett-Engele P., Lim L. P., Bartel D. P. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 27, 91–105 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Friedman R. C., Farh K. K.-H., Burge C. B., Bartel D. P. (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19, 92–105 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Kertesz M., Iovino N., Unnerstall U., Gaul U., Segal E. (2007) The role of site accessibility in microRNA target recognition. Nat. Genet. 39, 1278–1284 [DOI] [PubMed] [Google Scholar]
  • 22. Johnson C. D., Esquela-Kerscher A., Stefani G., Byrom M., Kelnar K., Ovcharenko D., Wilson M., Wang X., Shelton J., Shingara J., Chin L., Brown D., Slack F. J. (2007) The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res. 67, 7713–7722 [DOI] [PubMed] [Google Scholar]
  • 23. Jackson A. L., Bartz S. R., Schelter J., Kobayashi S. V., Burchard J., Mao M., Li B., Cavet G., Linsley P. S. (2003) Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol. 21, 635–637 [DOI] [PubMed] [Google Scholar]
  • 24. Khan A. A., Betel D., Miller M. L., Sander C., Leslie C. S., Marks D. S. (2009) Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs. Nat. Biotechnol. 27, 549–555 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Ong S.-E., Blagoev B., Kratchmarova I., Kristensen D. B., Steen H., Pandey A., Mann M. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 1, 376–386 [DOI] [PubMed] [Google Scholar]
  • 26. Ong S.-E., Mann M. (2007) A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC). Nat. Protoc. 1, 2650–2660 [DOI] [PubMed] [Google Scholar]
  • 27. Selbach M., Schwanhäusser B., Thierfelder N., Fang Z., Khanin R., Rajewsky N. (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455, 58–63 [DOI] [PubMed] [Google Scholar]
  • 28. Wiœniewski J. R., Zougman A., Nagaraj N., Mann M. (2009) Universal sample preparation method for proteome analysis. Nat. Methods 6, 359–362 [DOI] [PubMed] [Google Scholar]
  • 29. Cox J., Mann M. (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367–1372 [DOI] [PubMed] [Google Scholar]
  • 30. Kersey P. J., Duarte J., Williams A., Karavidopoulou Y., Birney E., Apweiler R. (2004) The International Protein Index: an integrated database for proteomics experiments. Proteomics 4, 1985–1988 [DOI] [PubMed] [Google Scholar]
  • 31. Cox J., Matic I., Hilger M., Nagaraj N., Selbach M., Olsen J. V., Mann M. (2009) A practical guide to the MaxQuant computational platform for SILAC-based quantitative proteomics. Nat. Protoc. 4, 698–705 [DOI] [PubMed] [Google Scholar]
  • 32. Schwanhäusser B., Busse D., Li N., Dittmar G., Schuchhardt J., Wolf J., Chen W., Selbach M. (2011) Global quantification of mammalian gene expression control. Nature 473, 337–342 [DOI] [PubMed] [Google Scholar]
  • 33. Pruitt K. D., Tatusova T., Maglott D. R. (2005) NCBI Reference Sequence (RefSeq): a curated nonredundant sequence database of genomes, transcripts, and proteins. Nucleic Acids Res. 33, D501–D504 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Betel D., Koppal A., Agius P., Sander C., Leslie C. (2010) Comprehensive modeling of microRNA targets predicts functional nonconserved and noncanonical sites. Genome Biol. 11, R90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Trapnell C., Pachter L., Salzberg S. L. (2009) TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105–1111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Kim D., Pertea G., Trapnell C., Pimentel H., Kelley R., Salzberg S. L. (2013) TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions, and gene fusions. Genome Biol. 14, R36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Trapnell C., Williams B. A., Pertea G., Mortazavi A., Kwan G., van Baren M. J., Salzberg S. L., Wold B. J., Pachter L. (2010) Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511–515 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Trapnell C., Roberts A., Goff L., Pertea G., Kim D., Kelley D. R., Pimentel H., Salzberg S. L., Rinn J. L., Pachter L. (2012) Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 7, 562–578 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Couts K. L., Anderson E. M., Gross M. M., Sullivan K., Ahn N. G. (2013) Oncogenic B-Raf signaling in melanoma cells controls a network of microRNAs with combinatorial functions. Oncogene 32, 1959–1970 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Baek D., Villén J., Shin C., Camargo F. D., Gygi S. P., Bartel D. P. (2008) The impact of microRNAs on protein output. Nature 455, 64–71 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Yang Y., Chaerkady R., Beer M. A., Mendell J. T., Pandey A. (2009) Identification of miR-21 targets in breast cancer cells using a quantitative proteomic approach. Proteomics 9, 1374–1384 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Chen Q.-R., Yu L.-R., Tsang P., Wei J. S., Song Y. K., Cheuk A., Chung J.-Y., Hewitt S. M., Veenstra T. D., Khan J. (2011) Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a. J. Proteome Res. 10, 479–487 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Leivonen S.-K., Rokka A., Östling P., Kohonen P., Corthals G. L., Kallioniemi O., Perälä M. (2011) Identification of miR-193b targets in breast cancer cells and systems biological analysis of their functional impact. Mol. Cell. Proteomics 10, M110.005322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Kaller M., Liffers S.-T., Oeljeklaus S., Kuhlmann K., Röh S., Hoffmann R., Warscheid B., Hermeking H. (2011) Genome-wide characterization of miR-34a induced changes in protein and mrna expression by a combined pulsed SILAC and microarray analysis. Mol. Cell. Proteomics 10, M111.010462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Lewis B. P., Burge C. B., Bartel D. P. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15–20 [DOI] [PubMed] [Google Scholar]
  • 46. Nielsen C. B., Shomron N., Sandberg R., Hornstein E., Kitzman J., Burge C. B. (2007) Determinants of targeting by endogenous and exogenous microRNAs and siRNAs. RNA 13, 1894–1910 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Raymond C. K., Roberts B. S., Garrett-Engele P., Lim L. P., Johnson J. M. (2005) Simple, quantitative primer-extension PCR assay for direct monitoring of microRNAs and short-interfering RNAs. RNA 11, 1737–1744 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Schmittgen T. D., Lee E. J., Jiang J., Sarkar A., Yang L., Elton T. S., Chen C. (2008) Real-time PCR quantification of precursor and mature microRNA. Methods 44, 31–38 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Bhattacharyya S. N., Habermacher R., Martine U., Closs E. I., Filipowicz W. (2006) Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 125, 1111–1124 [DOI] [PubMed] [Google Scholar]
  • 50. Goswami S., Tarapore R. S., TeSlaa J. J., Grinblat Y., Setaluri V., Spiegelman V. S. (2010) MicroRNA-340-mediated degradation of microphthalmia-associated transcription factor mRNA is inhibited by the coding region determinant-binding protein. J. Biol. Chem. 285, 20532–20540 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 51. Jafarifar F., Yao P., Eswarappa S. M., Fox P. L. (2011) Repression of VEGFA by CA-rich element-binding microRNAs is modulated by hnRNP L. EMBO J. 30, 1324–1334 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Kedde M., Strasser M. J., Boldajipour B., Vrielink J. A. F. O., Slanchev K., le Sage C., Nagel R., Voorhoeve P. M., van Duijse J., Ørom U. A., Lund A. H., Perrakis A., Raz E., Agami R. (2007) RNA-binding protein Dnd1 inhibits microRNA access to target mRNA. Cell 131, 1273–1286 [DOI] [PubMed] [Google Scholar]
  • 53. Kundu P., Fabian M. R., Sonenberg N., Bhattacharyya S. N., Filipowicz W. (2012) HuR protein attenuates miRNA-mediated repression by promoting miRISC dissociation from the target RNA. Nucleic Acids Res. 40, 5088–5100 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Mukherjee N., Corcoran D. L., Nusbaum J. D., Reid D. W., Georgiev S., Hafner M., Ascano M., Jr., Tuschl T., Ohler U., Keene J. D. (2011) Integrative regulatory mapping indicates that the RNA-binding protein HuR couples pre-mRNA processing and mRNA stability. Mol. Cell 43, 327–339 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Hansen T. B., Jensen T. I., Clausen B. H., Bramsen J. B., Finsen B., Damgaard C. K., Kjems J. (2013) Natural RNA circles function as efficient microRNA sponges. Nature 495, 384–388 [DOI] [PubMed] [Google Scholar]
  • 56. Poliseno L., Salmena L., Zhang J., Carver B., Haveman W. J., Pandolfi P. P. (2010) A coding-independent function of gene and pseudogene mRNAs regulates tumor biology. Nature 465, 1033–1038 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57. Fabian M. R., Sonenberg N., Filipowicz W. (2010) Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 79, 351–379 [DOI] [PubMed] [Google Scholar]
  • 58. Djuranovic S., Nahvi A., Green R. (2012) miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science 336, 237–240 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Bazzini A. A., Lee M. T., Giraldez A. J. (2012) Ribosome profiling shows that miR-430 reduces translation before causing mRNA decay in zebrafish. Science 336, 233–237 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Baccarini A., Chauhan H., Gardner T. J., Jayaprakash A. D., Sachidanandam R., Brown B. D. (2011) Kinetic analysis reveals the fate of a microRNA following target regulation in mammalian cells. Curr. Biol. 21, 369–376 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61. Gantier M. P., McCoy C. E., Rusinova I., Saulep D., Wang D., Xu D., Irving A. T., Behlke M. A., Hertzog P. J., Mackay F., Williams B. R. G. (2011) Analysis of microRNA turnover in mammalian cells following Dicer1 ablation. Nucleic Acids Res. 39, 5692–5703 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Rüegger S., Groβhans H. (2012) MicroRNA turnover: when, how, and why. Trends Biochem. Sci. 37, 436–446 [DOI] [PubMed] [Google Scholar]
  • 63. Asangani I. A., Rasheed S. a. K., Nikolova D. A., Leupold J. H., Colburn N. H., Post S., Allgayer H. (2007) MicroRNA-21 (miR-21) post-transcriptionally down-regulates tumor suppressor Pdcd4 and stimulates invasion, intravasation, and metastasis in colorectal cancer. Oncogene 27, 2128–2136 [DOI] [PubMed] [Google Scholar]
  • 64. Liang X., Zhou D., Wei C., Luo H., Liu J., Fu R., Cui S. (2012) MicroRNA-34c enhances murine male germ cell apoptosis through targeting ATF1. PLoS One 7, e33861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65. Schotte D., Chau J. C. K., Sylvester G., Liu G., Chen C., van der Velden V. H. J., Broekhuis M. J. C., Peters T. C. J. M., Pieters R., Boer M. L. den. (2008) Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic. Leukemia 23, 313–322 [DOI] [PubMed] [Google Scholar]
  • 66. Bousquet M., Harris M. H., Zhou B., Lodish H. F. (2010) MicroRNA miR-125b causes leukemia. Proc. Natl. Acad. Sci. 107, 21558–21563 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Data

Articles from Molecular & Cellular Proteomics : MCP are provided here courtesy of American Society for Biochemistry and Molecular Biology

RESOURCES